presentation of john mountzouris in 1st international antibody validation forum 2014
DESCRIPTION
John Mountzouris completed his Ph.D. in Medicinal Chemistry at the University of Texas, with a focus on structural biology, followed by a post-doctorate at the Scripps Research Institute. His industrial career begin with a stint as a bench scientist Pharmingen (later acquired by Becton Dickinson). He then turned to the business side, with work in sales and marketing, business development and communication at Pfizer, Abgent, and Acris Antibodies. Most recently, he has returned as Site Leader at Abgent, following its acquisition by Wuxi, a global CRO company. For more details about 1st international antibody validation forum please check on http://www.stjohnslabs.com/ac_cms/blogTRANSCRIPT
Antibody Validation:
Discovery Demands It
•A dream you have will come true with
antibodies.
•A very attractive person has a message for
you
about antibodies.
•Nothing astonishes so much as common
sense and
plain dealing with antibodies.
•Integrity is the essence of everything
successful
with antibodies
•To be old and wise, you must first be young
and
stupid with antibodies.
•The most important thing in communication is
to
hear what isn’t being said about antibodies.
From Prophecy To Validation
A Few More
Customers are expecting an antibody to work the first and every
time used
Customers are seeking proof of antibody quality
A majority of commercially available antibodies lack sufficient
information to enable an informed choice by the customer
Even where data is available, lot-to-lot testing is often not
performed, leading to the purchase of unqualified antibodies
Consequently, customers spend time and precious sample
validating and optimizing commercial antibodies – time that should
be used on their research efforts
Expectations of Antibody Consumers
Customer pain points with research antibodies
Poor quality accounts for >50% of
pain
Specificity – proper controls and models to ensure specificity
Sensitivity – detects endogenous levels of antigen
Reproducibility – reproducible within and between lots
Biological Relevance – tested in the correct model
system under the correct conditions
Some Principles Behind Good Antibody Validation
Validated Western Blotting Methodology
Example method; cell/tissue lysis
Two or more verified cell lines or tissue lysates run
Defined controls to ensure specificity, sensitivity, and reproducibility
Defined lysis and western protocols
Thorough antibody optimization and data preparation
Additional validation including IF, IHC, FC, IP and ChIP
Western blotting highlights
• MW of band should not deviate +20% or -10% of estimated MW, in presence of two controls: positive
(unpurified sera) and negative (naïve sera).
• Positive deviation (observed is heavier than expected) must be justified by PTMs
• Under-shifts due to truncated isoforms, and isoforms must cross-react with the immunogen sequence
• Estimated MW, PTMs, and isoforms must be obtained/confirmed via UniProt (UP)
• Peptide blocking with 3 increasing concentrations
• Bands are blocked gradually and the band at highest concentration disappears
• The species of cell lines/tissues used is identical to the target protein
• Positive in minimum of two cell lines/tissues
• Number of non-specific bands is less than 2, and weaker than specific band
• Test minimum of 2 dilutions (1:500, 1000) for antibody
• Embedded MW marker system must be deployed and used in conjunction with each approved test -
selected products
Western Blot Standards
There Are Consequences For Quality
Short-Term and Long-Term
• Customer Satisfaction
• Market Position
• Resource Allocation
• Scientific Impact
Product Pipeline Database (PPD) – Image Viewer
D1 Dopamine Receptor
AntibodyUBE2K Antibody
SPHK1 Antibody
Validation Data – Western Blot
Validation Data - Flow
G1=R1control
Human peripheral blood
lymphocytes stained with
purified OKT3, followed by
anti-mouse IgGs Alexa Fluor
488.
control G1=R1
R1
R2
Human peripheral blood
lymphocytes stained with
purified 4B2, followed by
anti-mouse IgGs Alexa Fluor
488.
R1: Human peripheral
blood lymphocytes
R2: Human peripheral
blood monocytes
Validation Data - Immunohistochemistry
Validation Data - Immunofluorescence
High throughput Western Blot Platform
Mature IF/IHC/FC Platform
Fluorescence microscope Flow cytometry instrumentHigh throughput –Flow cytometry instrument
Tissue slicing machine Paraffin embedding machine Microscope
Specialized Cell Room
Professional technical tea
m
Crowd Sourcing Validation – A Success Story
Specialty Meetings
Validation Leaders
Educational Materials
Lab Reach Out
Data
Accelerating Scientific Impact
Validation Partnering
Autophagy
Phosphorylation
Targets
Validation Leaders Publications
ISO9001:2008 (Certificate number
CN07/00676)
Suzhou animal facility is fully
accredited by AAALAC
International (Unit number 1326)
Lab Certifications:
The Validation of Validation
Discovery Demands It
“To know even one
life has breathed
easier because you
have lived. This is
the meaning of
success.”
- Ralph Waldo
Emerson